Closely held Kaleo dropped a lawsuit alleging Adamis infringed three patents for a proposed copycat of its Evzio auto-injector antidote to opioid overdoses.
- No details or mention of a settlement in notice posted July 18 in federal court in Wilmington, Delaware
- Patents for Evzio expire in February and May 2031 and in January 2034, according to supplemental filing
- NOTE: Kaleo Sues Adamis to Block Copies of Opioid-Overdose Antidote
- CASE: Kaleo Inc. v. Adamis Pharmaceuticals Corp., 19-cv-917, U.S. District Court, Delaware (Wilmington)
©2019 Bloomberg L.P. All rights reserved. Used with permission
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.